Figure 1From: Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?Spearman's correlation between modified Stoke ankylosing spondylitis spinal score (mSASSS) and lumbar spine bone mineral density (BMD).Back to article page